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Abstract  
Chronic obstructive pulmonary disease (COPD) in humans, describes a group of lung 
conditions characterised by airflow limitation that is poorly reversible. The airflow limitation 
usually progresses slowly and is related to an abnormal inflammatory response of the lung to 
toxic particles. COPD is characterised by oxidative stress and an increased risk of lung 
carcinoma. The 2-amino-3-methylimidazo [4,5-f]quinoline (IQ) is one of a number of 
mutagenic/carcinogenic heterocyclic amines found mainly in well-cooked meats which are 
thus part of the regular diet. Antioxidants are very important in order to protect the cells 
against oxidative damage. The aim of the present study was to assess the effects of IQ on the 
level of DNA damage and susceptibility to a potent mutagen in peripheral blood cells of 
COPD patients. DNA damage and the frequency of micronuclei were evaluated using the 
Comet and micronucleus assays, respectively. Differential expressions of both mRNA and 
protein of the endogenous antioxidant enzyme catalase were evaluated with quantitative 
polymerase chain reaction (qPCR) and Western blot analysis, respectively. Furthermore, the 
effect of bulk and nano forms of quercetin and their combination with IQ were examined. 
Results of the present study clearly demonstrated that micronucleus (MNi) frequency in the 
peripheral blood lymphocytes exhibited a positive correlation with the DNA damage as 
evident from the different Comet assay parameters. Increase of the endogenous antioxidant 
catalase also showed there was a stimulation of this enzyme system by IQ. Whereas, the 
endogenous antioxidant quercetin significantly reduced oxidative stress in COPD patients and 
healthy individuals. 
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Introduction  
Oxidative stress has important implications for numerous events of chronic obstructive 
pulmonary disease (COPD) pathophysiology and has been shown to be one of the major 
features in the pathogenesis of COPD (Rabe et al., 2007). The sources of increased oxidative 
stress in the respiratory compartment of COPD patients has been shown to be associated with 
an  increased burden of inhaled oxidants from environmental exposures and increased 
generation of reactive oxygen species (ROS) by several inflammatory and structural cells of 
the airways (Rahman, 2005), Such an increase in the number of reactive nitrogen species 
(RNS) which are released during leukocyte and macrophage production (Rahman and 
Adcock, 2006). ROS are highly reactive molecules which are produced from oxygen 
metabolism and can damage cell structures such as, nucleic acids and proteins resulting in 
alterations in their functions (Birben et al., 2012). The results of oxidative stress can occur by 
direct or indirect ROS-mediated damage of nucleic acids and proteins and are associated with 
carcinogenesis (Trachootham et al., 2009). 
Studies have reported that cigarette smoking is the main risk factor in COPD patients, but up 
to one-third of COPD patients have never smoked, implying that there are other factors 
involved (Varraso and Camargo, 2014; Yoshida and Tuder, 2007). Comparatively little 
attention has been paid to these other factors, such as intake and their alteration could 
decrease the global burden of COPD (Varraso and Camargo, 2014). A high intake of meat, 
mainly red and processed meat has been related to an increased risk of a number of chronic 
diseases such as cancer (Zheng and Lee, 2009). Heterocyclic aromatic amines (HCAs) are a 
group of mutagenic and/or carcinogenic compounds found in cooked meats which play a 
critical role in the etiology of human cancer (Felton et al., 2007a; Knize and Felton, 2005). 
These compounds are formed during the cooking process of meat from the reaction of 
creatinine and amino acids and can also generate ROS (Kizil et al., 2011). It has also been 
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shown that they can cause oxidation of proteins and DNA, leading to oxidative stress, DNA 
damage and can alter biological functions (Felton et al., 2007b; Knize and Felton, 2005). A 
study has shown that one potential mechanism between processed meat intake and the risk of 
COPD is due to nitrites to added meat products as preservatives and colour fixatives (Jakszyn 
et al., 2004). These nitrites could generate reactive nitrogen species (RNS) which increase 
inflammatory procedures in the airways and lung parenchyma, resulting in DNA damage and 
nitrosative stress (Varraso and Camargo, 2014). Another study showed that nitrosative stress 
can affect pulmonary function and is associated with the pathogenesis of COPD (Ricciardolo 
et al., 2006). A further study has suggested another possible mechanism of advanced 
glycation end-product (AGEs). This protein can occur naturally and is formed during heat 
processing and has been found to be associated with pro-inflammatory actions (Vlassara and 
Uribarri, 2014). The 2-Amino-3-methylimidazo [4,5-f] quinolone (IQ) is one of several 
HCAs carcinogens and is classified by the International Agency of Research on Cancer 
(IARC) as 2A (Jakszyn et al., 2004).   
The balance between these probably carcinogenic compounds and the protective actions of 
the antioxidant defences system, particularly those derived from intake, might play a critical 
role in pulmonary function and the ultimate development of COPD (Varraso and Camargo, 
2014). The cellular redox homeostasis is maintained by a complex endogenous antioxidant 
defence system, and includes endogenous antioxidant enzymes such as catalase. It is well 
established that the antioxidant defence system in humans is intricate and should aid to 
control the levels of ROS while permitting the valuable roles of ROS to perform cell 
signalling and redox regulation (Halliwell, 2011). The exogenous antioxidants derived from 
fruit and vegetables have shown that they support the endogenous antioxidant defence. The 
flavonoid antioxidants, like quercetin are presently considered to be one of the main 
exogenous antioxidants. Clinical studies imply that eating a diet rich in fruit, vegetables, 
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whole grains, legumes, and omega-3 fatty acids can help humans in disease prevention 
(Domej et al., 2014a). 
In the present study, the DNA damage was evaluated using the Comet and micronucleus 
assays in peripheral blood lymphocytes of patients with COPD disease and healthy 
individuals, using the nanoparticle (NP) and bulk versions of the flavonoid , quercetin. The 
mRNA and protein expression levels of catalase were also examined using qPCR and 
Western blot. We also examined the changes in oxidant-antioxidant imbalance of the catalase 
gene related to counteracting the aggregation of oxidative stress in human lymphocytes in 
patients with COPD. Thus, trying to map pathways affected by IQ exposure and suggesting a 
possible mechanism for its cytotoxic behaviour.   
Materials and methods 
Chemicals 
IQ (CAS No. 5346-56-5) were purchased from Toronto Research Chemicals, North York, 
Ont., Canada (Lage, Germany) and quercetin (≥95% purity; CAS No. 117-39-5) were 
purchased from the Sigma-Aldrich Company Ltd. (Sigma Chemical Ltd., Gillingham, UK). 
All other chemicals used in the different tests were from Sigma-Aldrich Company Ltd. 
(Sigma Chemical Ltd., Gillingham, UK). Prior to their use IQ and quercetin were dissolved in 
DMSO and excipient, respectively. The structural formulae of the tested chemicals are shown 
in Figure 1.  
Collection of samples  
After informed consent, approximately 10 ml heparinised blood was taken by venepuncture 
from the COPD patients at the Department of Ambulatory Care Unit (ACU), Bradford Royal 
Infirmary (BRI) Hospital, Bradford, UK. Healthy control individuals’ samples were taken 
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within the University of Bradford, UK (West Yorkshire, UK). Ethical permission was 
obtained from Leeds East Ethics Committee (Reference no: 12/YH/0464) and the University 
of Bradford’s Sub-Committee for Ethics in Research involving Human Subjects (Reference 
no.: 0405/8).  
Isolated Lymphocytes  
Three millilitres whole blood was diluted 3:3 with 0.9% saline and total of this dilution was 
carefully layered on top of three ml of Lymphoprep (Axis-Shield, Norway) in 15 ml falcon 
tubes. The tubes were centrifuged for 20 minutes at 800 × g. Lymphocytes were harvested, 
washed with 10 ml saline and centrifuged again for 15 min at 500 × g at room temperature. 
Cells were re-suspended in Roswell Park Memorial Institute (RPMI) 1640 Medium and used 
for the in vitro experiments. 
Cell viability  
The viability of lymphocytes was checked before and after treatment at the concentrations 
chosen for each experiment. Viability was measured by the Trypan blue exclusion test 
indicating intact cell membranes (Phillips, 1973). Ten microliters of 0.05% Trypan blue were 
added to 10 μl of cell suspension and the percentage of cells excluding the dye was estimated 
using an improved Neubauer haemocytometer (Poolzobel et al., 1992).  
Treatment of lymphocytes  
Isolated lymphocytes (2 x 10
5
) from COPD patients (n=10) and healthy controls (n=10) were 
treated without metabolic activation for 30 minutes (Comet assay). There was also a negative 
control (untreated cells) and positive control (60 µM H2O2). For (qPCR and Western blot) in 
RPMI at 37 ºC either with different form (bulk and nano) of quercetin (40µM) in the presence 
of IQ (140 µM) for 2 h. Lymphocytes from healthy individuals served as the negative control 
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group. After treatment, the cells were used in the Comet assay to detect DNA damage 
primarily single-strand breaks and alkali labile sites, and in the MNi assay to detect 
cytogenetic DNA damage. The antioxidant enzyme catalase was evaluated by qPCR and 
Western blot assays to quantify mRNA and protein levels respectively.  
Comet assay 
The Comet assay was processed with slight modifications according to Tice (Tice et al., 
(2000) and OECD, (2016)). In brief, the lymphocytes were mixed with prewarmed 0.5% low 
melting agarose (LMP) (Invitrogen, Paisley, UK: 15517-022). This cell suspension was 
transferred to slides pre-coated with 1% normal melting point (NMP) agarose, and covered 
with a coverslip. The slides were solidified on an ice block for 5 min, the coverslip was 
removed, and slides were incubated in cold lysing buffer (2.5 M NaCl, 100 mM EDTA, 10 
mM Tris, pH 10, with 1% Triton X-100 and 10% DMSO added just before use) and kept 
overnight at 4°C. The slides were placed on a horizontal gel electrophoresis platform to allow 
the DNA to unwind in a cold fresh electrophoresis buffer (300 mM NaOH and 1 mM 
Na2EDTA, pH ∼13.5) at 4°C, and electrophoresis was performed at 4°C for 30 min. The 
slides were then neutralized with a 400 mM Tris (pH 7.5) buffer for 5 min. The slides were 
stained with ethidium bromide (Sigma) and covered with a coverslip. Slides were examined 
by a computerized image analysis system (Comet 6.0; Andor Technology, Belfast, UK). One 
hundred cells were scored per sample (50 cells from each slide); Olive tail moment (OTM) 
and % tail DNA were measured as DNA damage parameters.  
The cytokinesis block micronucleus (CBMN) assay 
Five hundred microliters of whole blood was added to a T25 cm
2
 Corning culture flask 
containing 4.5 ml RPMI-1640 medium supplemented with 1% of Penicillin-streptomycin, 
15% Foetal bovine serum and 25 mM HEPES and L-Glutamine with end concentrations of 
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15 and 1%, respectively, followed by 100 μl of phythaemagglutinin (PHA) (2.5%). In the 
next 24 h, 50 μl of excipient (original solution) was added to the negative control. 50 μl of 
mitomycin C (0.4 μM) was added to the positive control. 140 µM of IQ and 25 µM quercetin 
from both bulk and nano forms were added to the rest of the flasks. Cultures were incubated 
at 37°C in the presence of 5% CO2 for 44 h. After 44 h, cytochalasin-B (6 μg/ml, Sigma) was 
added and the cultures were incubated for another 28 h. The CBMN test preparations were 
performed according to Fenech et al. ( Fenech et al., (2003 and 2007) and OECD (2016)). 
Various cytological parameters were evaluated: including cell mitotic status, mononucleated 
cells (MonoNC), binucleated cells (NC), multinucleated cells (MultiNC), other nuclear 
anomalies such as nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs) were also 
evaluated as biomarkers of genotoxic events. MNi, NBPs, and NBUDs were scored in NC up 
to 500 cells. 500 other cells were scored to calculate the percentages of each type of cells: 
Mono, NC, and MultiNC. The nuclear division index (NDI) was used as an indicator of the 
cytotoxicity and the rate of mitotic division and the calculation was used as described by 
Fenech, (2007). 
Total RNA isolation and cDNA synthesis 
Total RNA was extracted from lymphocytes (2 × 10
5
) using the GenElute Mammalian Total 
RNA Purification kit (Sigma-Aldrich, UK). The RNA was treated with DNase I (Sigma-
Aldrich, UK) to remove any DNA contaminants. The purity of total RNA was determined by 
measuring the absorbance at 260 and 280 nm (A260/280) ratios, using a NanoDrop™ 
Spectrophotometer. Random hexamer primed reverse transcription reactions were performed 
for 400 ng of total RNA in a 20 μl setup using ImProm-II™ Reverse Transcription System 
reaction following the manufacturer’s instructions (Promega). The samples were eluted in 30 
µL elution solution and stored at −20 °C until analysis by qPCR. 
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Quantitative PCR 
The reactions were performed using the StepOnePlus™ real-time PCR instrument (Applied 
Biosystems). The qPCR was used to measure the mRNA expression level of catalase in 
lymphocytes. Each reaction was prepared in triplicate and consisted of 5 µl of 
10 × SYBR
®
 Green PCR Master Mix (Applied Biosystems), 12.5 pmol each of forward and 
reverse primers, and 2 μl of cDNA template, making up to a 10 µl final volume per well. The 
qPCR was initially conducted at 50°C and 95°C for 2 and 20s, respectively, followed by 
amplification of the template for 40 cycles (each cycle involved 15 s at 95°C and 30s at 
60°C). The data were analysed by StepOne™ Software v 2.2.2. The cycle threshold (Ct) 
mean value for the target gene was used to calculate the relative expression with the relative 
quantification (RQ) value and formula: RQ = 2
-ΔCT
 × 100, where ΔCT = CT of target gene - 
CT of an endogenous housekeeping gene. Evaluation of 2
-ΔCT
 indicates the fold change in 
gene expression, normalized to the internal control (β-actin) which enables the comparison 
between differently treated cells.  
Western blot analysis  
The cells were lysed within the wells using lysis buffer (60 mM Tris, 2 % SDS, 100 mM 
DTT) on ice for 10 min and protein concentrations were then determined with a commercial 
kit (Bradford Protein Assay, Biorad, UK). Samples were subjected in 10 % SDS 
polyacrylamide gel and separated proteins were transferred to a PVDF membrane. The blots 
were blocked with blocking buffer (Tris-buffered saline, 0.5 % skim milk powder, and 0.1 % 
Tween-20) for 1 h at room temperature, and subsequently incubated overnight at 4°C with 
primary antibody against catalase with anti- catalase (1:2000; Abcam, Cambridge, UK), and 
mouse monoclonal anti-GAPDH (1:1,000; Abcam, Cambridge, UK). The blots were washed 
three times in TBST (TBS, 0.1 % Tween-20). The blots were then incubated with the 
secondary horseradish peroxidase-conjugated antibodies (1:1,000; Cell Signaling 
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Technology, UK) for 1h at room temperature. The bands were visualized using enhanced 
chemiluminescence assay kit (GE Healthcare, UK) in the Biorad ChemiDoc MP imaging 
system and density measurements were made using commercial software (Bio-Rad Quantity 
One).  
Statistical Analysis 
All the experiments were performed in duplicate and repeated at least three times. Results are 
expressed as means ± SEM of three experiments and data were analysed using one-way 
analysis of variance with Dunnett’s post hoc test to determine significance relative to control; 
for all experiments, a p ≤ 0.05 was considered significant. 
Results 
The responses of lymphocytes from healthy individuals and COPD patients to IQ for the 
Comet assay parameters OTM and % tail DNA are shown in Table I, Figures 2 and 3. A 
significant increase was shown in OTM and % tail DNA in the lymphocytes from healthy 
individuals from 19.24 (OTM) and 47.99 % (% tail DNA) compared to the untreated control 
groups to 4.26 (OTM) 13.02 % (% tail DNA), respectively, when cells were treated with 140 
µM IQ. Thus, cells were treated with 140 µM IQ and 25 µM Q-NPs for 30 mins and showed 
significant decreases in OTM and % tail DNA from 19.24 to 8.75 (OTM) and 47.99 to 17.63 
(% tail DNA) respectively (***p ≤ 0.001).  
Lymphocytes from COPD patients also showed that a significant increase in OTM and % tail 
DNA from 27.11 (OTM) and 49.18 % (% tail DNA) compared to the untreated control 
groups to 5.25 (OTM) and 19.62 % (% tail DNA), respectively, when cells were treated with 
140 µM IQ. Furthermore, cells treated with 140 µM IQ and 25 µM Q-NPs for 30 mins 
showed significant decreases in OTM and % tail DNA from 27.11 to 10.14 (OTM) and 49.18 
to 26.63 (% tail DNA) respectively (***p ≤ 0.001). Results also showed that following 
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exposure to IQ in the presence of quercetin bulk form and NPs, the levels of OTM and % tail 
DNA significantly decreased (
##p ≤ 0.01 and ###p ≤ 0.001 respectively) in lymphocytes from 
healthy individuals and CODP patients. The results also indicated that there was a statistically 
significant difference between the two forms (**p ≤ 0.01) Table I Figure 2 and 3.  
Our results in the CBMN assay also indicated that exposure to IQ showed clear evidence of 
cytogenetic damage in the groups of healthy individuals and COPD patients. In the CBMN 
assay, various parameters were evaluated: binucleated cells (BN), multinucleated cells (MN), 
binucleated with micronuclei (BN with MNi), nucleoplasmic bridges (NPBs) and nuclear 
buds (N-Buds). Table II showed that there was no significant difference in the Comet length 
and MNi frequency in both groups after treatment with IQ. The results also showed that 
following exposure to IQ in the presence of bulk and NPs forms, significantly reduced the 
MNi frequencies by both forms. Also quercetin showed significant differences between the 
bulk and nano forms (**p ≤ 0.01).  Thus, the extent of DNA damage by the Comet assay in 
lymphocyte cells was perfectly mirrored by the CBMN assay and MNi frequency can be used 
with the same effectiveness in the early detection of DNA damage in COPD patients. 
To determine whether catalase overexpression by ROS was reversible, cells were treated with 
IQ and the levels of catalase mRNA was determined in lymphocytes from COPD patients. 
Figure 4 shows that IQ significantly increased mRNA expression of catalase compared with 
untreated cells over 2 h. Thus, lymphocytes treated with 140 µM IQ in the presence of 25 µM 
Q-BPs for 2 h showed significant decreases in the mRNA expression level of catalase 
compared with the same cells treated with 140 µM IQ and 25 µM Q-NPs for 2 h (Figure 4).  
Catalase expression was also measured at the protein level by the quantitative Western blot 
method in COPD patients at 2 h. A statistically significant increase was shown in the levels 
of catalase protein at 2 h (***p<0.001). Thus, lymphocytes treated with 140 µM IQ in the 
presence of 25 µM Q-BPs for 2 h showed significant decreases in the protein level of catalase 
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compared with the same cells treated with 140 µM IQ and 25 µM Q-NPs for 2 h (
##
p ≤ 0.01 
and 
###
p ≤ 0.001 respectively) (Figures 5 A and B). Also quercetin showed significant 
differences between the bulk and nano forms (**p ≤ 0.01).  
Discussion  
Exposure to exogenous environmental carcinogens has become one of the most important 
causes of human cancers. Monitoring the DNA damage response in pathologies has been 
increasingly performed and might add another aspect to their clinical appearance. In addition 
to representing a potential target for therapeutic intervention in the treatment of COPD 
disorders. It is known that oxidative stress is a major pathogenetic component of the airway 
inflammation that is characteristic for COPD (Domej et al., 2014b). The increased oxidative 
burden present in COPD has been found to be associated with a range of pathogenic 
processes. These started with inactivation of antiproteases and enhancing bronchial 
inflammation by activating redox-sensitive transcription factors such as mucus 
hypersecretion and damage to pulmonary cells, activation of macrophages, neutrophils and 
fibroblasts (Hansel and Barnes, 2009; Rabe et al., 2007).  
The present study has examined DNA damage in the Comet and micronucleus assays in 
peripheral blood lymphocytes of healthy individuals and patients with COPD using the 
nanoparticle (NP) and bulk suspensions of the quercetin. In the Comet assay and in the MN 
assay, the results clearly showed that there was significantly an increase in the Comet 
parameters (OTM and % Tail DNA) and an increase in number of MNi in cells treated with 
IQ when compared to their untreated lymphocytes in healthy individual and COPD patients. 
Furthermore, DNA damage was a decrease in lymphocytes from healthy individuals and 
COPD patient after treatment with Q-BPs and Q-NPs and showed a significant reduction in 
DNA damage in both the Comet and MN assays. Based on this result, we also studied 
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whether there is regulation of catalase enzyme activity by IQ at the protein or gene 
expression levels.   
HCAs like IQ have been shown to be potent mutagens and exert strong carcinogenic effects 
in mammalian tissues (Sugimura, 2002; Sugimura et al., 2000). HCAs have also shown 
different types of DNA damage by interacting directly with DNA through the formation of 
covalent adducts. Most of the HCAs undergo metabolic activation by N-hydroxylation of the 
exocyclic amine group to producer the arylnitrenium ion, which is the significant metabolite 
implicated in toxicity and DNA damage (Hatch et al., 2001). HCAs have also induced genetic 
damage that can lead to mutations. These mutations are a vital event for the beginning of 
carcinogenesis; reducing these could be an important key of prevention for cancers (De Flora 
and Ferguson, 2005).  
A study has shown that IQ induced significant DNA damage in lymphocytes from 
inflammatory bowel disease (IBD) patients as a result of oxidative stress (Najafzadeh et al., 
2009). Flavonoids are important antioxidants and play a significant role in carcinogen 
deactivation in vivo (Dolara et al., 2005). Flavonoids like quercetin are known to modulate 
effects of HCAs in human lymphocytes and sperm in vitro (Anderson et al., 1998). The 
results in this study indicated that quercetin may have a beneficial role in lowering IQ 
toxicity. Another important finding of this study was that quercetin (NPs) had higher 
reduction effects at 25 µM concentration than quercetin (BPs). This implied that NPs have 
distinctive physicochemical properties display toxic effects that are different from their bulk 
counterparts (Harman et al., 2002; McDonald et al., 2005).  
The impact of IQ on the endogenous antioxidant enzyme catalase was additionally tested in 
lymphocytes from COPD patients with respect to the generation of oxidative stress such as 
ROS. The results showed that catalase significantly increases in mRNA expression levels and 
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protein activity may play an essential role in induced DNA damage in COPD patients. 
Consistent with the decreased level of DNA damage was reduced catalase expression at both 
the protein and mRNA levels in the present of quercetin at BPs and NPs forms. The results 
provide evidence that the effects of IQ could contribute to ROS generation and plays an 
important role in regulating catalase expression and in the pathogenesis of COPD. To our 
knowledge, this is the first in vitro study showing that IQ causes DNA damage by 
enhancement of ROS, endogenous and exogenous antioxidants involved. In cells, ROS are 
the primary cause of oxidative damage, which has long been identified as an initiating factor 
and altering antioxidant molecule function in the pathogenesis of COPD (McGuinness and 
Sapey, 2017). Catalase is one of the major endogenous antioxidant enzymes involved in 
defending cells from the damaging effects of ROS and disruption of normal cellular 
homeostasis via redox signalling could result in cancer (Bhattacharyya et al., 2014).  The 
functional polymorphisms of the catalase gene may significantly be involved in the 
pathogenesis of COPD. Stimulation or reduced levels of catalase or non-functionality of the 
catalase gene may lead to oxidative stress and initiate stress-related pathways. Also, the 
endogenous antioxidant quercetin significantly reduced oxidative stress in healthy individuals 
and COPD patients. 
Together, these results show that IQ-mediated ROS generation was adequate to recruit 
additional scavenger enzymes to defend diseased cells against oxidative stress-mediated 
DNA damage. Thus, IQ significantly stimulated the catalase pathway in human healthy in 
COPD patients. 
Conclusion  
To our knowledge, no study has assessed the association of high intake of well-done meat 
intake with COPD risk. These results are consistent with the mutagenic/carcinogenic effect of 
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IQ in animal models and suggest that HCA exposure may contribute to the development of 
the pathogenesis in COPD disease. The ability of flavonoids to reduce oxidative stress and 
induce human protective enzyme systems appear promising, in vitro in lymphocytes of 
COPD patients as well as healthy individuals, Thus, flavonoids and flavonoid-containing 
foods could be very beneficial in reducing oxidative DNA damage of COPD patients and so 
reduce the risk of potential cancer and other human illness. 
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Table I DNA damage induced in vitro in lymphocytes from healthy individuals and COPD patients by the food 
mutagen IQ (140 µM) its reduction by flavonoid supplementation with 25 µM of quercetin (Q). Data represent 
the means ± SE obtained from ten healthy individuals and ten patients with COPD. 
 Treatment Olive tail moment (OTM)           % Tail DNA 
Mean ± SE 
Healthy Individuals Untreated 4.26 ± 0.51 13.02  ± 0.43 
Positive Control (PC) 60 μM H2O2 19.56 ± 0.71*** 40.21± 1.51*** 
 IQ 140 µM 19.24± 0.72 *** 45.61 ± 1.49 *** 
 25 µM and Q-BPs 15.80 ± 1.55 ## 32.10  ± 0.90 ## 
 25 µM and Q-NPs 8.75 ± 0.59  ### 17.99  ± 1.25 ### 
COPD Patients Untreated 5.25 ± 0.68 21.46  ± 0.85 
Positive Control (PC) 60 μM H2O2 22.88± 0.57*** 41.50± 1.31*** 
 IQ 140 µM 27.11 ± 0.56 *** 47.18  ± 1.09 *** 
 25 µM and Q-BPs 16.40 ± 1.02 ## 37.07  ± 0.61 ## 
 25 µM and Q-NPs 10.14± 0.67 ### 22.99  ± 0.46 ### 
Q-BPs= Bulk quercetin, Q-NPs= Nano quercetin, PC= Positive control, ***p < 0.001 versus untreated cells and a positive control (PC) of 
60 µM H2O2. 
##p < 0.01and ###p < 0.001 indicates cells treated with 140 µM IQ and 25µM Q-BPs and 25µM Q-NPs. **P < 0.01 indicates 
comparison of bulk and nano. 
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Table II The CBMN assay detects the outcome of lesions such as micronuclei, nucleoplasmic bridges or nuclear 
buds in lymphocytes by the food mutagen IQ (140 µM) and its reduction by flavonoid supplementation with 25 
µM of quercetin (Q). Data represent the means ± SE obtained from three healthy individuals and three patients 
with COPD. 
Treatment                              NID                   % NC                         MNi                 NPBS                   Buds                    % MonoNC 
                                                    Mean ± SE 
Healthy individuals       
  Untreated  1.3 ± 0.40 80 ± 1.71 4 ±.0.03 2 ± 0.06 1 ± 0.04 58.4 ± 1.22 
  Mitomycin C (PC) 1.4 ± 0.12 67.2± 1.46 13 ± 0.53 *** 4 ± 0.13 3 ± 0.07 70.4 ± 1.02 
  IQ 140 µM 1.4 ± 0.04 69.6 ±  1.23 19 ±  0.72 *** 2 ±  0.04 3  ±  0.02 62.8 ±  1.54 
  25 µM and Q-BPs 1.3 ± 0.14 73.6 ± 1.45 14 ± 0.78 ## 4 ± 0.12 5 ± 0.17 60.6 ± 2.43 
  25 µM and Q-NPs 
 
1.3 ± 0.34 75.6 ± 1.98 9 ±0.56   ### 7 ± 0.17 7 ± 0.23 61 ± 2.5 
COPD Patients       
  Untreated  1.3 ± 0.02 71.5 ± 1.46 3 ± 0.57 2 ± 0.07 1  ± 0.02 67.4 ± 1.09 
  Mitomycin C (PC) 1.4 ± 0.04 57.2 ± 1.09 12 ± 0.43 *** 5 ± 0.16 5 ± 0.67 75.3 ± 1.12 
  IQ 140 µM 1.4 ± 0.05 72.4 ±  1.05 18 ±  0.75 *** 2 ±  0.06 5  ± 0.12 72.4 ±  1.05 
  25 µM and Q-BPs 1.4 ± 0.23 78.6 ±  1.34 15 ± 0.89 ## 4 ± 0.18 4 ± 0.16 62.5 ± 0.78 
  25 µM and Q-NPs 1.4 ± 0.12 72.6 ± 2.34    9 ±0.34 ### 7 ± 0.13 3 ± 0.12 67 ± 1.96 
Q-BPs= Bulk quercetin, Q-NPs= Nano quercetin, PC= Positive control, NDI= Nuclear division index, NC=Binucleated cells, % NC, is% 
expressed out of all types of 500 cells scored. MNi=Micronuclei score/500 cells each of NC, NPBs=Nucleoplasmic bridges and 
NBUDs=Nuclear buds.***p < 0.001 versus untreated cells and a positive control (PC) of 0.4 M of Mitomycin C (MMC). ##p < 0.01and ###p 
< 0.001 and indicates cells treated with 140 µM IQ and 25µM Q-BPs and 25 µM Q-NPs.  
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Figure legends 
Figure 1. Chemical structure of IQ and quercetin  
Figure 2. DNA damage measured as mean OTM before and after treatment with bulk 
and nano forms of quercetin in human lymphocytes from healthy individuals and 
COPD patients in the Comet assay. n= (10 in each group). *** P < 0.001 when 
compared with untreated lymphocytes and a positive control (PC) of 60 µM H2O2. 
##p < 0.01 and ###p < 0.001 indicates cells treated with 140 μM IQ and 25 µM Q-
BPs and Q-NPs. **P < 0.01 indicates comparison of bulk and nano.  
Figure 3. DNA damage measured as mean % tail DNA before and after treatment 
with bulk and nano forms of quercetin in human lymphocytes from healthy individuals 
and COPD patients in the Comet assay. n= (10 in each group). *** P < 0.001 when 
compared with untreated lymphocytes and a positive control (PC) of 60 µM H2O2. 
##p < 0.01 and ###p < 0.001 indicates cells treated with 140 μM IQ and 25 µM Q-
BPs and Q-NPs. **P < 0.01 indicates comparison of bulk and nano.  
Figure 4. Effect of IQ on the catalase mRNA expression in lymphocytes from COPD 
by qPCR. The COPD lymphocytes were incubated with or without IQ (140 µM), and 
with bulk and nano form of quercetin (25 µM and Q-BPs and 25 µM and Q-NPs) in 
the presence of IQ (140 µM) for 2 h for total RNA isolation and the expression of the 
catalase mRNA were determined by qPCR. Data from three different COPD patients 
(n=3). Figure shows change of catalase mRNA level at each time point. *** P < 0.001 
when compared with untreated lymphocytes. ##p < 0.01 and ###p < 0.001 indicates 
cells treated with 140 μM IQ and 25 µM Q-BPs and Q-NPs. **P < 0.01 indicates 
comparison of bulk and nano.  
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Figure 5 A and B. Effect of IQ on catalase expression in lymphocytes from COPD 
patients by Western blot. COPD lymphocytes were incubated with or without IQ (140 
µM), and with bulk and nano form of quercetin (25 µM and Q-BPs and 25 µM and Q-
NPs) in the presence of IQ (140 µM) for 2 h. (A): shows a representative blot 
indicating a protein band demonstrating catalase. (B): data (mean ± SE) are shown 
as a bar graph of densitometry data from three different COPD patients (n=3). *** P 
< 0.001 when compared with untreated lymphocytes. ##p < 0.01 and ###p < 0.001 
indicates cells treated with 140 μM IQ and 25 µM Q-BPs and Q-NPs. **P < 0.01 
indicates comparison of bulk and nano.  
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Figure 1                               
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Figure 2  
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Figure 3 
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Figure 5 
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